SCHEMBL14335594

SCHEMBL14335594

Cc1cc2nc3c(=O)n(CCN)c(=O)nc-3n(CCN)c2cc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.48
▸ TSHR P16473 1/20 0.48
▸ KDM4E B2RXH2 5/20 0.45
▸ USP2 O75604 4/20 0.45
▸ MEN1 O00255 3/20 0.45
▸ KMT2A Q03164 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ IDO1 P14902 2/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ ALDH1A1 P00352 4/20 0.43
▸ HPGD P15428 2/20 0.43
▸ GLA P06280 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ GAA P10253 1/20 0.39
▸ CASP7 P55210 3/20 0.38
▸ CASP1 P29466 2/20 0.38
▸ BRCA1 P38398 2/20 0.38
▸ RECQL P46063 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL15901355 0.99 CYP1A2 (0.50) CYP1A2TSHRKDM4EUSP2MEN1
Hydrochloric Acid SCHEMBL19405606 0.99 CYP1A2 (0.50) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15908045 0.95 KDM4E (0.46) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15666938 0.92 IDO1 (0.49) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15908043 0.90 CYP1A2 (0.39) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15908133 0.90 CYP1A2 (0.40) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15909976 0.90 CYP1A2 (0.40) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL19426969 0.89 CYP1A2 (0.39) CYP1A2TSHRKDM4EUSP2MEN1
SCHEMBL15908086 0.88 CYP1A2 (0.39) CYP1A2TSHRKDM4EUSP2MEN1
Hydrochloric Acid SCHEMBL17841707 0.88 CYP1A2 (0.41) CYP1A2TSHRKDM4EUSP2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3838902-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR PRODUCING SAME AND USE OF SAME TriOptoTec GmbH (DE) 2021-06-23 — — EP disclosed
US-20190111168-A1 PHOTOSENSITIZER DISPERSION, AND USE THEREOF UNIVERSITÄT REGENSBURG (DE) 2019-04-18 — — US disclosed
WO-2017167992-A1 PHOTOSENSITIVE DISPERSION AND USE THEREOF UNIVERSITÄT REGENSBURG (DE) 2017-10-05 — — WO disclosed
US-9745302-B2 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2017-08-29 — — US disclosed
US-9745302-B2 10H-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2017-08-29 — — US disclosed
US-20160176877-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH 2016-06-23 — — US disclosed
US-20160176877-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH 2016-06-23 — — US disclosed
US-9241995-B2 10H-benzo[G]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2016-01-26 — — US disclosed
US-9241995-B2 10H-benzo[G]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof TRIOPTOTEC GMBH (DE) 2016-01-26 — — US disclosed
US-20140212459-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2014-07-31 — — US disclosed
US-20140212459-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TRIOPTOTEC GMBH (DE) 2014-07-31 — — US disclosed
EP-2723742-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF Trioptotec GmbH (DE) 2014-04-30 — — EP disclosed
WO-2012175729-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF TriOpto Tec GmbH (DE) 2012-12-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160176877-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF DHPS, DOHH, PAH CYP1A2 325/4885TSHR 4234/4885KDM4E 376/4885
US-20140212459-A1 10H-BENZO[G]PTERIDINE-2,4-DIONE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF DHPS, DOHH, PAH CYP1A2 325/4885TSHR 4234/4885KDM4E 376/4885
US-20190111168-A1 PHOTOSENSITIZER DISPERSION, AND USE THEREOF PPOX, ALAD, PPID CYP1A2 281/4885TSHR 4734/4885KDM4E 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback